Retrospective Analysis of the Efficacy of Dapagliflozin in Patients with Type 2 Diabetes in a Primary Clinic in Korea

BACKGROUND: We aimed to retrospectively analyze the efficacy of 10 mg dapagliflozin (DAPA), which is a sodium-glucose cotransporter-2 inhibitor, in Korean patients with type 2 diabetes who visited a primary diabetes clinic. METHODS: In total, 83 patients with type 2 diabetes, who received treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sang Hyun, Choi, Young Ju, Rhee, Eun-Jung, Huh, Kab Bum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435850/
https://www.ncbi.nlm.nih.gov/pubmed/30912340
http://dx.doi.org/10.3803/EnM.2019.34.1.70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435850/
https://www.ncbi.nlm.nih.gov/pubmed/30912340
http://dx.doi.org/10.3803/EnM.2019.34.1.70

Ejemplares similares